Preclinical biotech developing novel T cell engagers for solid tumors.
Industry: Health Care
Latest Trade: $41.26 0.00 (0.0%)
First Day Return: +47.9%
Return from IPO: +142.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/19/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 11.4 |
Deal Size ($mm) | $194 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/10/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 11.4 |
Deal Size ($mm) | $194 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | La Jolla, CA, United States |
Founded | 2017 |
Employees at IPO | 16 |
Website www.januxrx.com |